Skip to main content
Erschienen in: Rheumatology International 5/2012

01.05.2012 | Case Report

Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies

verfasst von: Hasan Ulusoy

Erschienen in: Rheumatology International | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare but extremely disabling genetic disease of the skeletal system. This disease is characterized by progression of heterotopic ossification within skeletal muscles, ligaments and tendons. Most patients with FOP are misdiagnosed early in life before the appearance of heterotopic ossification and undergo diagnostic procedures such as biopsy that can cause lifelong disability. Almost all of the patients have some peculiar congenital anomalies, including short great toes, hallux valgus, short thumbs and hypoplasia of digital phalanges. These congenital defects support the diagnosis of FOP, but are not constantly observed in the totality of patients. If necessary, genetic studies can be performed to confirm the diagnosis. Once diagnosed, patients should be advised in order to avoid unnecessary traumas, surgical procedures, biopsies, intramuscular injections and vaccinations. Here, we describe a patient with FOP without characteristic congenital skeletal anomalies.
Literatur
1.
Zurück zum Zitat Smith R (1998) Fibrodysplasia (myosistis) ossificans progressiva: clinical lessons from a rare disease. Clin Orthop 346:7–14PubMed Smith R (1998) Fibrodysplasia (myosistis) ossificans progressiva: clinical lessons from a rare disease. Clin Orthop 346:7–14PubMed
2.
Zurück zum Zitat Semonin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 102:314–317PubMedCrossRef Semonin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 102:314–317PubMedCrossRef
3.
Zurück zum Zitat Shore EM, Feldman GJ, Xu M, Kaplan FS (2005) The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:201–204CrossRef Shore EM, Feldman GJ, Xu M, Kaplan FS (2005) The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:201–204CrossRef
4.
Zurück zum Zitat Mahboubi S, Glaser DL, Shore EM, Kaplan FS (2001) Fibrodysplasia ossificans progressiva. Pediatr Radiol 31:307–314PubMedCrossRef Mahboubi S, Glaser DL, Shore EM, Kaplan FS (2001) Fibrodysplasia ossificans progressiva. Pediatr Radiol 31:307–314PubMedCrossRef
5.
Zurück zum Zitat Puszczewicz M, Kolczewska A, Gorska IZ, Majewski D, Ogrodowicz A (2007) Fibrodysplasia ossificans progressiva: case report. Pol Arch Med Wewn 117:53–56PubMed Puszczewicz M, Kolczewska A, Gorska IZ, Majewski D, Ogrodowicz A (2007) Fibrodysplasia ossificans progressiva: case report. Pol Arch Med Wewn 117:53–56PubMed
6.
Zurück zum Zitat Palhares DB, Leme LM (2001) A perspective on the control of myositis ossificans progressiva. J Pediatr (Rio J) 77:431–434 Palhares DB, Leme LM (2001) A perspective on the control of myositis ossificans progressiva. J Pediatr (Rio J) 77:431–434
7.
Zurück zum Zitat Connor JM, Evans DAP (1982) Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg 64(B):76–83 Connor JM, Evans DAP (1982) Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg 64(B):76–83
8.
Zurück zum Zitat Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J et al (2009) Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 121:1295–1300CrossRef Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J et al (2009) Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 121:1295–1300CrossRef
9.
Zurück zum Zitat Rogers JG, Geho WB (1979) Fibrodysplasia ossificans progressiva. A survey of forty-two cases. J Bone Joint Surg 61A:909–914 Rogers JG, Geho WB (1979) Fibrodysplasia ossificans progressiva. A survey of forty-two cases. J Bone Joint Surg 61A:909–914
10.
Zurück zum Zitat Schroeder HW, Zasloff MA (1980) The hand and foot malformations in fibrodysplasia ossificans progressiva. Johns Hopkins Med J 147:73–78PubMed Schroeder HW, Zasloff MA (1980) The hand and foot malformations in fibrodysplasia ossificans progressiva. Johns Hopkins Med J 147:73–78PubMed
11.
Zurück zum Zitat Cohen RB, Hahn GV, Tabas J, Peeper J, Levitz CL, Sando A et al (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 75:215–219PubMed Cohen RB, Hahn GV, Tabas J, Peeper J, Levitz CL, Sando A et al (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 75:215–219PubMed
12.
Zurück zum Zitat Kaplan FS, Merrer ML, Glaser DL, Pignolo RJ, Goldsby R, Kitterman JA et al (2008) Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 22:191–205PubMedCrossRef Kaplan FS, Merrer ML, Glaser DL, Pignolo RJ, Goldsby R, Kitterman JA et al (2008) Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 22:191–205PubMedCrossRef
13.
Zurück zum Zitat Pignolo RJ, Suda RK, Kaplan FS (2005) The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metab 3:195–200CrossRef Pignolo RJ, Suda RK, Kaplan FS (2005) The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metab 3:195–200CrossRef
14.
Zurück zum Zitat Moriatis JM, Gannon FH, Shore EM, Bilker W, Zasloff MA, Kaplan FS (1997) Limb swelling in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Rel Res 336:247–253CrossRef Moriatis JM, Gannon FH, Shore EM, Bilker W, Zasloff MA, Kaplan FS (1997) Limb swelling in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Rel Res 336:247–253CrossRef
15.
Zurück zum Zitat Kussmaul WG, Esmail AN, Sagir AN, Ross J, Gregory S, Kaplan FS (1998) Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva. Clin Orthop 346:104–109PubMed Kussmaul WG, Esmail AN, Sagir AN, Ross J, Gregory S, Kaplan FS (1998) Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva. Clin Orthop 346:104–109PubMed
16.
Zurück zum Zitat Schaffer AA, Kaplan FS, Tracy MR, O’Brien ML, Dormans JP, Shore EM et al (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome. Spine 30:1379–1385PubMedCrossRef Schaffer AA, Kaplan FS, Tracy MR, O’Brien ML, Dormans JP, Shore EM et al (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome. Spine 30:1379–1385PubMedCrossRef
17.
Zurück zum Zitat Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P et al (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:183–188CrossRef Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P et al (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:183–188CrossRef
18.
Zurück zum Zitat Miller ES, Esterly NB, Fairley JA (1996) Progressive osseous heteroplasia. Arch Dermatol 132:787–791PubMedCrossRef Miller ES, Esterly NB, Fairley JA (1996) Progressive osseous heteroplasia. Arch Dermatol 132:787–791PubMedCrossRef
19.
Zurück zum Zitat Sanmartin O, Alegre V, Martinez-Aparicio A, Botella-Estrada R, Aliaga A (1993) Congenital platelike osteoma cutis: case report and review of the literature. Pediatr Dermatol 10:182–186PubMedCrossRef Sanmartin O, Alegre V, Martinez-Aparicio A, Botella-Estrada R, Aliaga A (1993) Congenital platelike osteoma cutis: case report and review of the literature. Pediatr Dermatol 10:182–186PubMedCrossRef
20.
Zurück zum Zitat Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G et al (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med 322:1412–1419PubMedCrossRef Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G et al (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med 322:1412–1419PubMedCrossRef
21.
Zurück zum Zitat Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525–527PubMedCrossRef Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525–527PubMedCrossRef
22.
Zurück zum Zitat Lee DY, Cho TJ, Lee HR, Park MS, Yoo WJ, Chung CY et al (2009) ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. J Korean Med Sci 24:433–437PubMedCrossRef Lee DY, Cho TJ, Lee HR, Park MS, Yoo WJ, Chung CY et al (2009) ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. J Korean Med Sci 24:433–437PubMedCrossRef
23.
Zurück zum Zitat Furuya H, Ikezoe K, Wang L, Ohyagi Y, Motomura K, Fujii N et al (2008) A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet A 146:459–463 Furuya H, Ikezoe K, Wang L, Ohyagi Y, Motomura K, Fujii N et al (2008) A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet A 146:459–463
24.
Zurück zum Zitat Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R (2009) Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet 17:311–318PubMedCrossRef Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R (2009) Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet 17:311–318PubMedCrossRef
25.
Zurück zum Zitat Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L et al (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30:379–390PubMedCrossRef Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L et al (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30:379–390PubMedCrossRef
26.
Zurück zum Zitat Buyse G, Silberstein J, Goemans N, Casaer P (1995) Fibrodysplasia Ossificans Progressiva: still turning into wood after 300 years? Eur J Pediatr 154:694–699PubMedCrossRef Buyse G, Silberstein J, Goemans N, Casaer P (1995) Fibrodysplasia Ossificans Progressiva: still turning into wood after 300 years? Eur J Pediatr 154:694–699PubMedCrossRef
27.
Zurück zum Zitat Glaser DL, Kaplan FS (2005) Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:243–250CrossRef Glaser DL, Kaplan FS (2005) Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:243–250CrossRef
28.
Zurück zum Zitat Kaplan FS, Shore EM, Glaser DL, Emerson S (2003) The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Consort FOP 1:1–81 Kaplan FS, Shore EM, Glaser DL, Emerson S (2003) The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Consort FOP 1:1–81
29.
Zurück zum Zitat Kaplan FS, Shore EM, Glaser DL, Emerson S (2005) The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Clin Consort FOP 1:1–71 Kaplan FS, Shore EM, Glaser DL, Emerson S (2005) The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Clin Consort FOP 1:1–71
30.
Zurück zum Zitat Blaszczyk M, Majewski S, Wcislo LB, Jablonska S (2003) Fibrodysplasia ossificans progressiva. Eur J Dermatol 13:234–237PubMed Blaszczyk M, Majewski S, Wcislo LB, Jablonska S (2003) Fibrodysplasia ossificans progressiva. Eur J Dermatol 13:234–237PubMed
31.
Zurück zum Zitat Nucci A, Queiroz LDS, Santos ADO, Camargo E, Moura RM (2000) Fibrodysplasia ossificans progressiva. Arq Neuropsiquiatr 58:342–347PubMedCrossRef Nucci A, Queiroz LDS, Santos ADO, Camargo E, Moura RM (2000) Fibrodysplasia ossificans progressiva. Arq Neuropsiquiatr 58:342–347PubMedCrossRef
Metadaten
Titel
Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies
verfasst von
Hasan Ulusoy
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1426-1

Weitere Artikel der Ausgabe 5/2012

Rheumatology International 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.